Skip to content

Prohibiting Tianeptine and Other Dangerous Products Act of 2026

In committee: it can still change before the session ends.

US S 3797 · Senate Bill · 119th Congress

Draft a letter
Stage
In committee
Started in
Senate
Sponsors
2
Latest action
Feb 5, 2026

What it does

The bill would amend the Federal Food, Drug, and Cosmetic Act to prohibit the introduction into interstate commerce of dietary supplements that do not meet the legal definition of a dietary supplement or that are prepared, packed, or held with the assistance of a debarred person. It would also expand import exclusion and seizure authorities to cover violations of these new prohibitions. The measure primarily affects manufacturers, distributors, and importers of dietary supplements, particularly those involving substances like tianeptine, by strengthening federal enforcement against unsafe or non-compliant products.

No official summary is available here. This one was written by AI from the bill’s text.

Read the full textRead it on the official site

Where it stands

  1. Introduced (Done)

    Feb 5, 2026

  2. Committee (Current step)

    In committee · Feb 5, 2026

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

While a bill can still move, the questions are about people and money.

Work with this bill

Prohibiting Tianeptine and Other Dangerous Products Act of 2026 | 52